查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1631212

獸醫腫瘤學市場規模、佔有率、趨勢分析報告：按動物類型、治療方法、癌症類型、地區、細分市場預測，2025-2030 年

Veterinary Oncology Market Size, Share & Trends Analysis Report By Animal Type (Canine, Feline), By Therapy (Radiotherapy, Surgery), By Cancer Type, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

獸醫腫瘤學市場成長與趨勢：

預計2030年全球獸醫腫瘤市場規模將達31.1億美元，2025年至2030年複合年成長率預計為12.08%。

寵物癌症盛行率的增加和對獸醫診斷的需求預計將在預測期內推動市場發展。

全球採用犬癌症登記處來估計癌症發生率是市場成長的另一個促進因素。根據2019年2月《獸醫科學前沿》報道，瑞士犬癌症登記處（SCCR）被用作資料來源並進行彙編，以供未來犬類和人類癌症的比較研究。該資料庫進一步有助於減少人群中惡性腫瘤的發生，從而促進市場成長。

進行獸醫腫瘤學研究的研究人員正在進一步推動獸醫腫瘤學市場的成長。例如，2017 年 8 月，伊利諾大學進行了一項研究，旨在更準確地檢測狗的頭頸部腫瘤轉移（癌症在體內的擴散）。此外，市場公司也專注於新產品創新和策略聯盟。例如，2018 年，Oasmia Pharmaceutical AB 的子公司 AdvaVet 開發了基於奈米顆粒配方的 XR17 技術，該技術使單一活性藥物成分 (API) 或多種 API 水溶性。這是聯合治療，也是許多寵物癌症疾病的標準治療方法。

獸醫腫瘤學市場報告亮點

  • 伴同性動物癌症盛行率的不斷上升、評估寵物癌症治療的安全性和有效性的多項臨床試驗研究以及獸醫癌症治療的技術進步正在推動市場成長，預計將創造機會。
  • 化療在未來幾年中佔據了最大的收益佔有率，因為它擴大用於寵物的癌症治療，無論是單獨使用還是與其他治療方法結合使用。
  • 到2024年，狗的收益佔有率最大，超過86.09%，狗的數量不斷增加，而且與貓相比，狗的癌症患病率更高。
  • 截至 2024 年，北美佔據壓倒性佔有率。這是由於有利的政府政策、公司新產品的推出以及對獸醫癌症治療的巨額投資。
  • 由於對動物健康和支出的日益關注、患有癌症的寵物數量的增加、政府對動物安全的關注以及遏制寵物癌症病例的多項舉措，亞太地區正在迅速成長，預計將呈現良好的成長。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章 獸醫腫瘤市場的波動趨勢與範圍

  • 市場體系展望
    • 母市場
    • 輔助市場
  • 市場動態
    • 市場成長要素分析
    • 市場限制因素分析
    • 市場機會分析
    • 市場問題分析
  • 獸醫腫瘤學市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • 法律規範
    • 主要國家和主要物種的動物數量估計（2018-2023）
    • 產品價格分析
    • COVID-19 影響分析

第4章獸醫腫瘤學市場：按動物類型的估計和趨勢分析

  • 細分儀表板
  • 獸醫腫瘤學市場：按動物類型的波動分析
  • 按動物類型分類的獸醫腫瘤學市場規模和趨勢分析（2018-2030）
    • 狗
    • 貓
    • 馬

第5章獸醫腫瘤學市場：依治療方法進行估計與趨勢分析

  • 細分儀表板
  • 獸醫腫瘤學市場：治療方法波動分析
  • 獸醫腫瘤學市場規模與趨勢分析：依治療方法分類（2018-2030）
    • 放射治療
    • 外科手術
    • 化療
    • 免疫療法
    • 其他治療方法

第6章獸醫腫瘤學市場：按癌症類型分類的估計和趨勢分析

  • 細分儀表板
  • 獸醫腫瘤學市場：按癌症類型分類的波動分析
  • 獸醫腫瘤學市場規模和趨勢分析：按癌症類型（2018-2030）
    • 皮膚癌
    • 淋巴瘤
    • 肉瘤
    • 其他

第7章獸醫腫瘤學市場：按動物類型、治療方法和癌症類型進行的國家估計和趨勢分析

  • 區域儀表板
  • 獸醫腫瘤學市場佔有率：按地區（2023/2030）
  • 區域展望
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 市場參與企業分類
  • 市場公司概況
  • 財務表現
  • 產品基準
  • 2023年市場情勢分析（熱圖分析）
  • 策略規劃
    • 併購
    • 發射
    • 夥伴關係與協作
    • 擴張
    • 其他
  • 公司簡介
    • Elanco
    • Boehringer Ingelheim International GmbH
    • Zoetis
    • Elekta AB
    • PetCure Oncology
    • Accuray Incorporated
    • Varian Medical Systems, Inc.（parent company：Siemens Healthineers）
    • Virbac
    • Merck &Co., Inc.
    • Dechra Pharmaceuticals PLC
    • NovaVive Inc.
    • Ardent Animal Health, LLC（A BreakthrU Company）
Product Code: GVR-4-68038-182-5

Veterinary Oncology Market Growth & Trends:

The global veterinary oncology market size is expected to reach USD 3.11 billion in 2030 and is projected to grow at a CAGR of 12.08% from 2025 to 2030. Increasing prevalence of cancer in pets and demand for veterinary diagnostics are projected to drive the market over the forecast period.

Adoption of canine cancer registry globally to estimate cancer incidences is another driving factor for the market growth. According to frontiers in Veterinary Science in February 2019, the Swiss Canine Cancer Registry (SCCR) was used as a data source and was compiled for future comparative studies of canine and human cancers. This database is further helpful in mitigating the incidence of malignant tumors in the human population, thereby driving the market growth.

Researchers carrying out studies focused on veterinary oncology are further boosting the veterinary oncology market growth. For instance, University of Illinois in August 2017, carried out study that involves more precise detection of metastasis (spread of cancer through the body) for head and neck tumors in dogs. Moreover, the market players are also focusing on new product innovation and strategic collaborations. For instance, in 2018 AdvaVet, a subsidiary of Oasmia Pharmaceutical AB, developed XR17 technology, which is nanoparticle formulation based that makes a single Active Pharmaceutical Ingredient (API) or multiple APIs water soluble. It is a combination therapy and is also a standard treatment for a number of cancer diseases in pet animals.

Veterinary Oncology Market Report Highlights:

  • Increasing prevalence of cancer in companion animals, several clinical trial studies to evaluate the safety and effectiveness of cancer therapeutics for pets and technological advancements in veterinary oncology treatment are anticipated to create growth opportunities in the market.
  • Chemotherapy accounted for the largest revenue share over the coming years, owing to its increasing adoption for pet cancer treatment either alone or in combination with other therapies.
  • The canine segment held the largest revenue share of over 86.09% in 2024, increasing the population of dogs and high prevalence of cancer in dogs as compared to cats.
  • North America held the dominant share as of 2024, due to the favorable government policies, new product launch by the companies, and huge investment for veterinary oncology treatment.
  • Asia Pacific is anticipated to witness lucrative growth due to increasing focus on animal health and expenditure, increasing number of pet population being exposed to cancer, government focus on animal safety, and several initiatives to curb cancer cases in pet animals.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research
  • 1.4. Information/Data Analysis
  • 1.5. Market Formulation & Visualization
  • 1.6. Data Validation & Publishing
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis
    • 1.7.2. Global Market: CAGR Calculation
  • 1.8. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Veterinary Oncology Market Variable Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market
    • 3.1.2. Ancillary Market
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing prevalence of cancer in pets
      • 3.2.1.2. Increasing R&D in pet cancer therapy
      • 3.2.1.3. Growing focus on animal safety
      • 3.2.1.4. Growing uptake of pet insurance
      • 3.2.1.5. Technological advancements in pet cancer treatment
      • 3.2.1.6. Increase in pet population
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of treatment
      • 3.2.2.2. Adverse effects associated with therapies
      • 3.2.2.3. Limited clinical evidence
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. Veterinary Oncology Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitution
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental Landscape
    • 3.3.3. Regulatory Framework
    • 3.3.4. Estimated Animal Population, by Key Countries and Key Species, 2018-2023
    • 3.3.5. Product Pricing Analysis
    • 3.3.6. COVID-19 Impact Analysis

Chapter 4. Veterinary Oncology Market: Animal Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Veterinary Oncology Market Product Movement Analysis
  • 4.3. Veterinary Oncology Market Size & Trend Analysis, By Animal Type, 2018 - 2030 (USD Million)
    • 4.3.1. Canine
      • 4.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.3.2. Feline
      • 4.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.3.3. Equine
      • 4.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Veterinary Oncology Market: Therapy Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Veterinary Oncology Market Application Movement Analysis
  • 5.3. Veterinary Oncology Market Size & Trend Analysis, By Therapy, 2018 - 2030 (USD Million)
    • 5.3.1. Radiotherapy
      • 5.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.3.1.2. Stereotactic Radiation Therapy
        • 5.3.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
        • 5.3.1.2.2. LINAC
          • 5.3.1.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
        • 5.3.1.2.3. Other Types
          • 5.3.1.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.3.1.3. Conventional Radiation Therapy
        • 5.3.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.2. Surgery
      • 5.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.3. Chemotherapy
      • 5.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.4. Immunotherapy
      • 5.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.5. Other Therapies
      • 5.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Veterinary Oncology Market: Cancer Type Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Veterinary Oncology Market Animal Movement Analysis
  • 6.3. Veterinary Oncology Market Size & Trend Analysis, By Cancer Type, 2018 - 2030 (USD Million)
    • 6.3.1. Skin Cancers
      • 6.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.2. Lymphomas
      • 6.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.3. Sarcomas
      • 6.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.4. Others
      • 6.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Veterinary Oncology Market: Country Estimates & Trend Analysis, by animal type, therapy, & cancer type

  • 7.1. Regional Dashboard
  • 7.2. Veterinary Oncology Market Share, By Region, 2023 & 2030, USD Million
  • 7.3. Regional Outlook
  • 7.4. North America
    • 7.4.1. North America Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competition Insights
      • 7.4.2.3. U.S. Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competition Insights
      • 7.4.3.3. Canada Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competition Insights
      • 7.4.4.3. Mexico Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competition Insights
      • 7.5.2.3. UK Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competition Insights
      • 7.5.3.3. Germany Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competition Insights
      • 7.5.4.3. France Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competition Insights
      • 7.5.5.3. Italy Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competition Insights
      • 7.5.6.3. Spain Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competition Insights
      • 7.5.7.3. Denmark Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competition Insights
      • 7.5.8.3. Sweden Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competition Insights
      • 7.5.9.3. Norway Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competition Insights
      • 7.6.2.3. Japan Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competition Insights
      • 7.6.3.3. China Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competition Insights
      • 7.6.4.3. India Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competition Insights
      • 7.6.5.3. Australia Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competition Insights
      • 7.6.6.3. South Korea Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competition Insights
      • 7.6.7.3. Thailand Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competition Insights
      • 7.7.2.3. Brazil Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competition Insights
      • 7.7.3.3. Argentina Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Middle East & Africa
    • 7.8.1. Middle East & Africa Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competition Insights
      • 7.8.2.3. South Africa Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competition Insights
      • 7.8.3.3. Saudi Arabia Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competition Insights
      • 7.8.4.3. UAE Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competition Insights
      • 7.8.5.3. Kuwait Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Participants Overview
  • 8.3. Financial Performance
  • 8.4. Product Benchmarking
  • 8.5. Market Position Analysis, 2023 (Heat Map Analysis)
  • 8.6. Strategy Mapping
    • 8.6.1. MERGERS AND ACQUISITIONS
    • 8.6.2. LAUNCH
    • 8.6.3. PARTNERSHIPS & COLLABORATIONS
    • 8.6.4. EXPANSION
    • 8.6.5. OTHERS
  • 8.7. Company Profiles
    • 8.7.1. Elanco
      • 8.7.1.1. Participant's overview
      • 8.7.1.2. Financial performance
      • 8.7.1.3. Product Benchmarking
      • 8.7.1.4. Strategic initiatives
    • 8.7.2. Boehringer Ingelheim International GmbH
      • 8.7.2.1. Participant's overview
      • 8.7.2.2. Financial performance
      • 8.7.2.3. Product Benchmarking
      • 8.7.2.4. Strategic initiatives
    • 8.7.3. Zoetis
      • 8.7.3.1. Participant's overview
      • 8.7.3.2. Financial performance
      • 8.7.3.3. Product Benchmarking
      • 8.7.3.4. Strategic initiatives
    • 8.7.4. Elekta AB
      • 8.7.4.1. Participant's overview
      • 8.7.4.2. Financial performance
      • 8.7.4.3. Product Benchmarking
      • 8.7.4.4. Strategic initiatives
    • 8.7.5. PetCure Oncology
      • 8.7.5.1. Participant's overview
      • 8.7.5.2. Financial performance
      • 8.7.5.3. Product Benchmarking
      • 8.7.5.4. Strategic initiatives
    • 8.7.6. Accuray Incorporated
      • 8.7.6.1. Participant's overview
      • 8.7.6.2. Financial performance
      • 8.7.6.3. Product Benchmarking
      • 8.7.6.4. Strategic initiatives
    • 8.7.7. Varian Medical Systems, Inc. (parent company: Siemens Healthineers)
      • 8.7.7.1. Participant's overview
      • 8.7.7.2. Financial performance
      • 8.7.7.3. Product Benchmarking
      • 8.7.7.4. Strategic initiatives
    • 8.7.8. Virbac
      • 8.7.8.1. Participant's overview
      • 8.7.8.2. Financial performance
      • 8.7.8.3. Product Benchmarking
      • 8.7.8.4. Strategic initiatives
    • 8.7.9. Merck & Co., Inc.
      • 8.7.9.1. Participant's overview
      • 8.7.9.2. Financial performance
      • 8.7.9.3. Product Benchmarking
      • 8.7.9.4. Strategic initiatives
    • 8.7.10. Dechra Pharmaceuticals PLC
      • 8.7.10.1. Participant's overview
      • 8.7.10.2. Financial performance
      • 8.7.10.3. Product Benchmarking
      • 8.7.10.4. Strategic initiatives
    • 8.7.11. NovaVive Inc.
      • 8.7.11.1. Participant's overview
      • 8.7.11.2. Financial performance
      • 8.7.11.3. Product Benchmarking
      • 8.7.11.4. Strategic initiatives
    • 8.7.12. Ardent Animal Health, LLC (A BreakthrU Company)
      • 8.7.12.1. Participant's overview
      • 8.7.12.2. Financial performance
      • 8.7.12.3. Product Benchmarking
      • 8.7.12.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 Estimated cost of dog cancer treatment (2024)
  • Table 3 North America vet oncology average price by therapy category (USD, 2024)
  • Table 4 Estimated animal population by species & by country, 2018 to 2022
  • Table 5 Veterinary oncology market estimates & forecasts, by animal type, 2018 to 2030 (USD Million)
  • Table 6 Veterinary oncology market estimates & forecasts, by therapy, 2018 to 2030 (USD Million)
  • Table 7 Global radiotherapy market, by type, 2018 - 2030 (USD Million)
  • Table 8 Global stereotactic radiation therapy market, by type, 2018 - 2030 (USD Million)
  • Table 9 Veterinary oncology market estimates and forecast, by cancer type, 2018 - 2030 (USD Million)
  • Table 10 Ongoing veterinary sarcoma clinical trials at Colorado State University
  • Table 11 North America Veterinary Oncology Market, by Country, 2018 - 2030 (USD Million)
  • Table 12 North America Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 13 North America Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 14 North America Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 15 U.S. Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 16 U.S. Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 17 U.S. Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 18 Canada Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 19 Canada Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 20 Canada Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 21 Mexico Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 22 Mexico Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 23 Mexico Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 24 Europe Veterinary Oncology Market, by Country, 2018 - 2030 (USD Million)
  • Table 25 Europe Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 26 Europe Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 27 Europe Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 28 Germany Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 29 Germany Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 30 Germany Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 31 UK Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 32 UK Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 33 UK Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 34 France Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 35 France Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 36 France Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 37 Italy Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 38 Italy Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 39 Italy Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 40 Spain Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 41 Spain Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 42 Spain Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 43 Denmark Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 44 Denmark Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 45 Denmark Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 46 Sweden Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 47 Sweden Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 48 Sweden Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 49 Norway Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 50 Norway Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 51 Norway Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 52 Asia Pacific Veterinary Oncology Market, by Country, 2018 - 2030 (USD Million)
  • Table 53 Asia Pacific Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 54 Asia Pacific Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 55 Asia Pacific Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 56 China Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 57 China Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 58 China Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 59 Japan Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 60 Japan Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 61 Japan Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 62 India Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 63 India Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 64 India Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 65 South Korea Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 66 South Korea Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 67 South Korea Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 68 Australia Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 69 Australia Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 70 Australia Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 71 Thailand Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 72 Thailand Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 73 Thailand Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 74 Latin America Veterinary Oncology Market, by Country, 2018 - 2030 (USD Million)
  • Table 75 Latin America Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 76 Latin America Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 77 Latin America Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 78 Brazil Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 79 Brazil Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 80 Brazil Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 81 Argentina Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 82 Argentina Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 83 Argentina Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 84 Middle East & Africa Veterinary Oncology Market, by Country, 2018 - 2030 (USD Million)
  • Table 85 Middle East & Africa Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 86 Middle East & Africa Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 87 Middle East & Africa Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 88 South Africa Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 89 South Africa Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 90 South Africa Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 91 South Africa Veterinary Oncology Market, by End Use, 2018 - 2030 (USD Million)
  • Table 92 Saudi Arabia Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 93 Saudi Arabia Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 94 Saudi Arabia Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 95 UAE Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 96 UAE Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 97 UAE Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 98 Kuwait Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 99 Kuwait Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 100 Kuwait Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 101 Participants overview
  • Table 102 Financial performance
  • Table 103 Key market players pursuing approvals & clearances
  • Table 104 Key market players initiate mergers & acquisitions.
  • Table 105 Key market players initiate collaboration & partnerships.
  • Table 106 Key market players initiating product/ service launches/expansions
  • Table 107 Key market players undertaking R&D partnerships
  • Table 108 Key market players undertaking other activities.
  • Table 109 List of other key market players

List of Figures

  • Fig. 1 Veterinary oncology market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Data analysis models
  • Fig. 6 Market formulation and validation
  • Fig. 7 Data validation & publishing
  • Fig. 8 Volume x Price Analysis
  • Fig. 9 General methodology for commodity flow analysis of animal health market
  • Fig. 10 Commodity flow analysis
  • Fig. 11 Market snapshot
  • Fig. 12 Segment snapshot
  • Fig. 13 Segment snapshot
  • Fig. 14 Competitive landscape snapshot
  • Fig. 15 Veterinary oncology market value, 2024 (USD Billion)
  • Fig. 16 Ancillary market outlook, 2024
  • Fig. 17 Veterinary oncology market dynamics
  • Fig. 18 Basic annual expenses for dog and cat owners in USD (2024)
  • Fig. 19 veterinary oncology market: PORTER's analysis
  • Fig. 20 veterinary oncology market: PESTEL analysis
  • Fig. 21 Estimated number of veterinary service establishments in the U.S., 2018 to 2030
  • Fig. 22 Veterinary oncology market by animal type: key takeaways
  • Fig. 23 Veterinary oncology market by animal type, Market share, 2023 & 2030
  • Fig. 24 Canine market, 2018 - 2030 (USD Million)
  • Fig. 25 Feline market, 2018 - 2030 (USD Million)
  • Fig. 26 Equine market, 2018 - 2030 (USD Million)
  • Fig. 27 Veterinary oncology market by therapy: key takeaways
  • Fig. 28 Veterinary oncology market by therapy, market share, 2024 & 2030
  • Fig. 29 Radiotherapy market, 2018 - 2030 (USD Million)
  • Fig. 30 Stereotactic radiation therapy market, 2018 - 2030 (USD Million)
  • Fig. 31 LINAC market, 2018 - 2030 (USD Million)
  • Fig. 32 Others market, 2018 - 2030 (USD Million)
  • Fig. 33 Conventional radiation therapy market, 2018 - 2030 (USD Million)
  • Fig. 34 Surgery market, 2018 - 2030 (USD Million)
  • Fig. 35 Chemotherapy market, 2018 - 2030 (USD Million)
  • Fig. 36 Immunotherapy market, 2018 - 2030 (USD Million)
  • Fig. 37 Other therapies market, 2018 - 2030 (USD Million)
  • Fig. 38 Veterinary oncology market by cancer type: Key takeaways
  • Fig. 39 Veterinary oncology market by cancer type, market share, 2024 & 2030
  • Fig. 40 Skin Cancers market, 2018 - 2030 (USD Million)
  • Fig. 41 Lymphomas market, 2018 - 2030 (USD Million)
  • Fig. 42 Sarcomas market, 2018 - 2030 (USD Million)
  • Fig. 43 Others market, 2018 - 2030 (USD Million)
  • Fig. 44 Veterinary oncology market revenue, by region, 2023 & 2030 (USD Million)
  • Fig. 45 Regional market share analysis, 2023 & 2030
  • Fig. 46 Regional marketplace: key takeaways
  • Fig. 47 Regional marketplace: key takeaways
  • Fig. 48 Regional marketplace: key takeaways
  • Fig. 49 North America veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 U.S. veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Canada veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Mexico veterinary oncology market, 2018 - 2030 (USD Million)
  • Fig. 56 Europe veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 UK. veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 Germany veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 France veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Italy veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Spain veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Sweden veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Denmark veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Norway veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Rest of Europe veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Asia Pacific veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 Japan veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 China veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 India veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 South Korea veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Australia veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 Thailand veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Rest of Asia Pacific veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Latin America veterinary oncology market, 2018 - 2030 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 Brazil veterinary oncology market, 2018 - 2030 (USD Million)
  • Fig. 89 Argentina veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 Rest of Latin America veterinary oncology market, 2018 - 2030 (USD Million)
  • Fig. 91 MEA veterinary oncology market, 2018 - 2030 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 South Africa veterinary oncology market, 2018 - 2030 (USD Million)
  • Fig. 94 Saudi Arabia veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 UAE veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 Kuwait veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 97 Rest of MEA veterinary oncology market, 2018 - 2030 (USD Million)
  • Fig. 98 Market participant categorization
  • Fig. 99 Heat map analysis
  • Fig. 100 Key strategies deployed by market players